Introduction
Gonorrhea has outsmarted almost every antibiotic thrown at it. Sulfonamides, penicillin, tetracycline, fluoroquinolones, one by one, Neisseria gonorrhoeae has developed resistance to each antibiotic class used to treat it. Today, drug-resistant gonorrhea in Florida is not a distant concern, it is a present and growing threat that infectious disease specialists are actively monitoring and managing.
The stakes could not be higher. The CDC has classified drug-resistant gonorrhea as an urgent public health threat, the highest level of concern in its antibiotic resistance threat report. In Florida, where gonorrhea rates are already among the highest in the nation, the emergence of strains resistant to ceftriaxone, the last reliably effective antibiotic, represents a potential public health crisis. At Florida Infectious Disease Care, our board-certified specialists stay at the cutting edge of gonorrhea management to ensure every patient receives treatment that actually works.
Why Gonorrhea Develops Resistance So Effectively
Neisseria gonorrhoeae is biologically exceptional at developing antibiotic resistance. Several characteristics of the organism contribute to this:
- High mutation rate: Gonorrhea has a naturally high genetic mutation rate, allowing resistance mutations to arise frequently
- Horizontal gene transfer: The organism can acquire resistance genes from other bacteria in its environment, including other species sharing the same anatomical niche
- Natural competence: Gonorrhea readily takes up DNA from its environment and incorporates it into its own genome, a process that can transfer resistance genes between strains
- Anatomical sanctuary sites: Pharyngeal gonorrhea, infection of the throat, creates an environment where the organism is exposed to subtherapeutic antibiotic concentrations from medications intended for other purposes, selecting for resistance without effective treatment
According to the CDC’s National Gonorrhea Treatment Guidelines, the U.S. has relied on ceftriaxone as the sole recommended treatment since 2020, after the sequential failure of every other antibiotic class. The emergence of ceftriaxone resistance, already documented in isolated cases globally, would leave gonorrhea effectively untreatable with current antibiotics.
Drug-Resistant Gonorrhea Florida: The Local Picture
Florida’s position as one of the highest-burden states for gonorrhea nationally means it faces amplified risk from resistance emergence. High case volumes create more opportunities for resistant strains to emerge and spread. Lee County and surrounding Southwest Florida communities see consistently elevated gonorrhea rates that place residents at above-average exposure risk.
The Florida Department of Health actively monitors gonorrhea susceptibility patterns through sentinel surveillance programs. Our team at Florida Infectious Disease Care is connected to these surveillance systems and adjusts our clinical practice in real time based on local resistance data.
Symptoms of Gonorrhea — and Why It Often Goes Undetected
One of the most significant challenges in controlling gonorrhea, and therefore controlling resistance, is that many infections are asymptomatic:
- Men may experience urethral discharge and painful urination, but up to 10 percent have no symptoms
- Women are asymptomatic in approximately 50 percent of cases, making routine screening the only reliable detection method
- Pharyngeal gonorrhea (throat infection) is almost always asymptomatic
- Rectal gonorrhea may cause discharge, pain, or bleeding, but is frequently asymptomatic
Untreated gonorrhea causes pelvic inflammatory disease (PID) in women, leading to chronic pelvic pain, ectopic pregnancy, and infertility. In men, it can cause epididymitis and, rarely, infertility. Disseminated gonococcal infection, spread to the bloodstream, causes arthritis, skin lesions, and in rare cases, endocarditis or meningitis.
How Gonorrhea Is Currently Treated in Fort Myers
The current CDC-recommended treatment for gonorrhea is a single intramuscular injection of ceftriaxone 500mg (or 1g for patients weighing more than 150kg). This regimen replaced dual therapy, previously combined with azithromycin, after azithromycin resistance rates rendered that component ineffective.
A test-of-cure, retesting after treatment to confirm eradication, is recommended for all pharyngeal gonorrhea, all treatment failures, and for patients where treatment with a non-recommended regimen was necessary. Our team at Florida Infectious Disease Care performs test-of-cure as standard practice to confirm treatment success and immediately identify any treatment failures.
For patients diagnosed with gonorrhea, comprehensive STI screening is also performed at the same visit, because gonorrhea co-infection with chlamydia, syphilis, and HIV is common and all require simultaneous management.
The Emerging Treatment Pipeline
In anticipation of ceftriaxone treatment failure becoming widespread, researchers have been developing alternative gonorrhea treatments. Zoliflodacin, a novel antibiotic with a mechanism of action unlike any existing agent, demonstrated high efficacy in Phase 3 clinical trials published in the New England Journal of Medicine and received regulatory review. Gepotidacin is another candidate in advanced clinical development. Our team stays current with the evolving treatment landscape to ensure patients have access to the most effective options available.
Prevention: Reducing Gonorrhea Risk in Southwest Florida
Prevention remains the most effective strategy against drug-resistant gonorrhea:
- Get tested regularly — every three months if you have multiple partners, as recommended for patients on PrEP
- Use condoms consistently for vaginal, anal, and oral sex — condoms remain effective against gonorrhea
- Know that Doxy-PrEP provides some but not complete protection against gonorrhea, due to existing doxycycline resistance in some strains — it should not be relied upon as sole gonorrhea prevention
- Treat sexual partners when diagnosed — untreated partners will reinfect you regardless of your own treatment
- Ask your provider specifically whether your gonorrhea has been tested for antibiotic susceptibility — this is standard practice at Florida Infectious Disease Care
Our team offers comprehensive sexual health services including PrEP, PEP, Doxy-PrEP, and complete STI testing and treatment through our infectious disease practice.
Frequently Asked Questions
Q: How will I know if my gonorrhea is drug-resistant?
Standard gonorrhea treatment is administered before culture sensitivity results return. If your symptoms persist or do not resolve after treatment, or if a test-of-cure is positive, antibiotic susceptibility testing of the organism is performed. Our team reports every treatment failure immediately and adjusts therapy based on sensitivity data.
Q: Can I take oral antibiotics for gonorrhea instead of an injection?
No oral antibiotic is currently recommended as first-line gonorrhea treatment due to widespread resistance. Oral cefixime is no longer recommended because of concerns about reduced susceptibility. Ceftriaxone by injection is the only currently reliable treatment. If you have a concern about receiving an injection, please discuss it with your provider — but please do not seek or accept oral antibiotics alone as definitive gonorrhea treatment.
Q: If I have had gonorrhea before, am I immune to getting it again?
No. Gonorrhea does not confer protective immunity. You can acquire gonorrhea repeatedly from the same partner or from different partners. Each infection requires its own treatment, and each treated infection should include test-of-cure to confirm eradication. Repeat infections also increase the risk of complications including PID and disseminated infection.
Q: My gonorrhea test came back positive but I have no symptoms, do I still need treatment?
Absolutely. Asymptomatic gonorrhea is just as transmissible as symptomatic infection and carries the same risk of complications if untreated. A positive test result always requires treatment regardless of symptoms. Additionally, all recent sexual partners, typically within the past 60 days, should be notified and tested.
Ready to Get the Expert Care You Deserve?
At Florida Infectious Disease Care, our board-certified specialists bring decades of combined expertise to every patient encounter, with compassion, precision, and complete confidentiality. Whether you are navigating a new diagnosis, a recurring infection, or a prevention decision, we are the right team for you. Call us today at 239-245-8223 or visit us at 14192 Metropolis Ave, Fort Myers, FL 33912.
Book your appointment at floridaidcare.com/make-an-appointment or find us on Google Maps. Expert infectious disease care is closer than you think, and your health cannot wait.